Literature DB >> 24312833

High performance liquid chromatographic analysis of almotriptan malate in bulk and tablets.

Petikam Lavudu1, Avula Prameela Rani, Chepuri Divya, Chandra Bala Sekharan.   

Abstract

PURPOSE: A simple RP-HPLC method has been developed and validated for the determination of almotriptan malate (ATM) in bulk and tablets.
METHODS: Chromatographic separation of ATM was achieved by using a Thermo Scientific C18 column. A Mobile phase containing a mixture of methanol, water and acetic acid (4:8:0.1 v/v) was pumped at the flow rate of 1 mL/min. Detection was performed at 227 nm. According to ICH guidelines, the method was validated.
RESULTS: The calibration curve was linear in the concentration range 5-60 µg/mL for the ATM with regression coefficient 0.9999. The method was precise with RSD <1.2%. Excellent recoveries of 99.60 - 100.80% proved the accuracy of the method. The limits of detection and quantification were found to be 0.025 and 0.075 µg/mL, respectively.
CONCLUSION: The method was successfully applied for the quantification of ATM in tablets with acceptable accuracy and precision.

Entities:  

Keywords:  Almotriptan Malate; Analysis; HPLC; Tablets; Validation

Year:  2013        PMID: 24312833      PMCID: PMC3846065          DOI: 10.5681/apb.2013.030

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  8 in total

1.  Effect of food intake on the bioavailability of almotriptan, an antimigraine compound, in healthy volunteers: an open, randomized, crossover, single-dose clinical trial.

Authors:  J M Jansat; A Martinez-Tobed; E Garcia; X Cabarrocas; J Costa
Journal:  Int J Clin Pharmacol Ther       Date:  2006-04       Impact factor: 1.366

2.  LC-ESI-MS/MS determination of in vivo metabolites of almotriptan in rat plasma, urine and feces: application to pharmacokinetics.

Authors:  R Nageswara Rao; K Guruprasad; Ch Gangu Naidu; B Raju; R Srinivas
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-02-20       Impact factor: 3.205

3.  Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans.

Authors:  J C Fleishaker; K K Ryan; J M Jansat; B J Carel; D J Bell; M T Burke; N E Azie
Journal:  Br J Clin Pharmacol       Date:  2001-05       Impact factor: 4.335

4.  Oral almotriptan in the treatment of migraine: safety and tolerability.

Authors:  D W Dodick
Journal:  Headache       Date:  2001-05       Impact factor: 5.887

5.  Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine.

Authors:  Li-Chia Chen; Darren M Ashcroft
Journal:  Headache       Date:  2007-09       Impact factor: 5.887

Review 6.  Spotlight on almotriptan in migraine.

Authors:  Susan J Keam; Karen L Goa; David P Figgitt
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

7.  Development and Validation of HPTLC Method for the Estimation of Almotriptan Malate in Tablet Dosage Form.

Authors:  A Suneetha; B Syamasundar
Journal:  Indian J Pharm Sci       Date:  2010-09       Impact factor: 0.975

8.  Method development and validation of almotriptan in human plasma by HPLC tandem mass spectrometry: application to pharmacokinetic study.

Authors:  Konda Ravikumar; Babu Rao Chandu; Balasekhara Reddy Challa; Kottapalli B Chandrasekhar
Journal:  Sci Pharm       Date:  2012-02-27
  8 in total
  2 in total

1.  Development of Mucoadhesive Buccal Film for Rizatriptan: In Vitro and In Vivo Evaluation.

Authors:  Anroop B Nair; Jigar Shah; Shery Jacob; Bandar E Al-Dhubiab; Vimal Patel; Nagaraja Sreeharsha; Pottathil Shinu
Journal:  Pharmaceutics       Date:  2021-05-15       Impact factor: 6.321

2.  Mucoadhesive buccal film of almotriptan improved therapeutic delivery in rabbit model.

Authors:  Anroop B Nair; Bandar E Al-Dhubiab; Jigar Shah; Shery Jacob; Vismay Saraiya; Mahesh Attimarad; Nagaraja SreeHarsha; Sabah H Akrawi; Tamer M Shehata
Journal:  Saudi Pharm J       Date:  2019-12-07       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.